Report on how AI is redefining market landscape - The global gastroparesis drugs market size is estimated to grow by USD 1.42 ...

Pharmaceutical giant Merck(NYSE: MRK) is recognized for its extensive product portfolio of more than 52 drugs covering ...

Let us look at five large biotech and generic drug companies, NVO, GILD, MRNA, VTRS and TEVA, which are gearing up for their ...

Undoubtedly the biggest story of the week was the scrapping of the $160 billion merger between Pfizer ... diabetes treatments. Novo Nordisk recently released positive findings for its diabetes ...

With the rise of chronic diseases, technological advances and innovative drug pipelines are driving significant growth in the ...

With an array of new medicines and medical devices on display global medical companies are looking to tap further into the ...

Pharmaceutical company Viatris (VTRS 13.52%) reported third-quarter 2024 financial results on Thursday, Nov. 7, that topped ...

With an array of new medicines and medical devices on display, global medical companies are looking to tap further into the ...

The GLP-1 agonist was the first drug in the partnership ... recently approved for diabetes and in late-stage testing in obesity. For now, Rybelsus will be in Pfizer and Sosei Heptares' sights ...

"China market is one of the most attractive markets for Edwards," said Leo Tam, senior director of the business unit of Transcatheter Aortic Valve Replacement, Edwards Lifesciences China, citing a lot ...

What’s an example of a well-executed drug launch? Look no further than Reata’s commercialization of Skyclarys, the first ...

They are expected to act as a catalyst in medicine, society, the economy, and even in... fuel consumption - The astounding ...